ClinicalTrials.govpublic full text
A Phase I Open-Label Dose Escalation Study of Intravenous INKmune In Patients With MDS or AML
cancer, mds-eb, myelodysplastic syndromes, acute myeloid leukemia, aml, mds, nk cell based therapy, immune based therapy, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 803347
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.